Full Text View
Tabular View
Study Results
Related Studies
Rosuvastatin in Visceral Adiposity (RIVIERA)
This study has been completed.
Study NCT01068626   Information provided by Göteborg University

First Received on February 12, 2010.   Last Updated on February 7, 2011   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Abdominal Obesity
Additional conditions recognized in this trial
Obesity
Obesity, Abdominal
More general conditions related to this trial
Body Weight
Nutrition Disorders
Overnutrition
Overweight
Signs and Symptoms
Interventions listed in this trial
Rosuvastatin
Placebo for rosuvastatin
More general drug interventions related to this trial
Anticholesteremic Agents
Antimetabolites
Enzyme Inhibitors
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Hypolipidemic Agents
Lipid Regulating Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Göteborg University
Sahlgrenska University Hospital, Sweden


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services